<DOC>
	<DOCNO>NCT01298388</DOCNO>
	<brief_summary>RATIONALE : Studying medical record collect questionnaire patient enrol child clinical trial acute lymphoblastic leukemia may help doctor learn long-term effect treatment plan best treatment . PURPOSE : This clinical trial study long-term outcome patient acute lymphoblastic leukemia enrol child clinical trial EORTC-58741 , EORTC-58831 , EORTC-58832 , EORTC-58881 1971 1998 .</brief_summary>
	<brief_title>Study Long-Term Outcomes Patients With Acute Lymphoblastic Leukemia Who Were Enrolled Children Clinical Trials EORTC-58741 , EORTC-58831 , EORTC-58832 , EORTC-58881 Between 1971 1998</brief_title>
	<detailed_description>OBJECTIVES : - To assess long-term outcome ( i.e. , long-term survival , long-term disease status , occurrence late adverse effect , occurrence second cancer , socioeconomic status survivor ) patient acute lymphoblastic leukemia previously enrol child clinical trial EORTC-58741 , EORTC-58831 , EORTC-58832 , EORTC-58881 year 1971 1998 . OUTLINE : Long-term outcome data collect database clinical trial EORTC-58741 , EORTC-58831 , EORTC-58832 , EORTC-58881 . Other data collect include patient 's vital status actualization ( e.g. , alive , dead lose follow , date last known alive date death ) , medical record data , collection data patient confirm alive ( e.g. , data relate marital status , education , work , insurance , puberty , fertility , offspring ) questionnaire .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients acute lymphoblastic leukemia ( ALL ) previously enrol child ( less than18 year age diagnosis ) follow clinical trial 1971 1998 : EORTC58741 EORTC58831 EORTC58832 EORTC58881 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>long-term effect secondary cancer therapy child</keyword>
	<keyword>cancer survivor</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>untreated childhood acute lymphoblastic leukemia</keyword>
	<keyword>T-cell childhood acute lymphoblastic leukemia</keyword>
	<keyword>non-T , non-B childhood acute lymphoblastic leukemia</keyword>
	<keyword>non-T , non-B , cALLa positive childhood acute lymphoblastic leukemia</keyword>
	<keyword>non-T , non-B , cALLa negative childhood acute lymphoblastic leukemia</keyword>
	<keyword>non-T , non-B , cALLa positive , pre-B childhood acute lymphoblastic leukemia</keyword>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
</DOC>